<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Crit Care</journal-id><journal-id journal-id-type="iso-abbrev">Crit Care</journal-id><journal-title-group><journal-title>Critical Care</journal-title></journal-title-group><issn pub-type="ppub">1364-8535</issn><issn pub-type="epub">1466-609X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4470455</article-id><article-id pub-id-type="publisher-id">cc14205</article-id><article-id pub-id-type="doi">10.1186/cc14205</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Adjunct prednisone therapy for patients with community-acquired pneumonia: a randomized, placebo-controlled multicenter trial</article-title></title-group><contrib-group><contrib contrib-type="author" id="A1"><name><surname>Blum</surname><given-names>CA</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A2"><name><surname>Nigro</surname><given-names>N</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Briel</surname><given-names>M</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Schuetz</surname><given-names>P</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A5"><name><surname>Ullmer</surname><given-names>E</given-names></name><xref ref-type="aff" rid="I3">3</xref></contrib><contrib contrib-type="author" id="A6"><name><surname>Suter-Widmer</surname><given-names>I</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A7"><name><surname>Winzeler</surname><given-names>B</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A8"><name><surname>Bingisser</surname><given-names>R</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A9"><name><surname>Elsaesser</surname><given-names>H</given-names></name><xref ref-type="aff" rid="I3">3</xref></contrib><contrib contrib-type="author" id="A10"><name><surname>Drozdov</surname><given-names>D</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A11"><name><surname>Arici</surname><given-names>B</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A12"><name><surname>Urwyler</surname><given-names>SA</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A13"><name><surname>Refardt</surname><given-names>J</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A14"><name><surname>Tarr</surname><given-names>P</given-names></name><xref ref-type="aff" rid="I4">4</xref></contrib><contrib contrib-type="author" id="A15"><name><surname>Wirz</surname><given-names>S</given-names></name><xref ref-type="aff" rid="I4">4</xref></contrib><contrib contrib-type="author" id="A16"><name><surname>Thomann</surname><given-names>R</given-names></name><xref ref-type="aff" rid="I5">5</xref></contrib><contrib contrib-type="author" id="A17"><name><surname>Baumgartner</surname><given-names>C</given-names></name><xref ref-type="aff" rid="I6">6</xref></contrib><contrib contrib-type="author" id="A18"><name><surname>Duplain</surname><given-names>H</given-names></name><xref ref-type="aff" rid="I7">7</xref></contrib><contrib contrib-type="author" id="A19"><name><surname>Burki</surname><given-names>D</given-names></name><xref ref-type="aff" rid="I8">8</xref></contrib><contrib contrib-type="author" id="A20"><name><surname>Zimmerli</surname><given-names>W</given-names></name><xref ref-type="aff" rid="I3">3</xref></contrib><contrib contrib-type="author" id="A21"><name><surname>Rodondi</surname><given-names>N</given-names></name><xref ref-type="aff" rid="I6">6</xref></contrib><contrib contrib-type="author" id="A22"><name><surname>Mueller</surname><given-names>B</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A23"><name><surname>Christ-Crain</surname><given-names>M</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib></contrib-group><aff id="I1"><label>1</label>University Hospital Basel, Switzerland</aff><aff id="I2"><label>2</label>Medical University Clinic, Kantonsspital Aarau, Switzerland</aff><aff id="I3"><label>3</label>Kantonsspital Baselland/Liestal, Liestal, Switzerland</aff><aff id="I4"><label>4</label>Kantonsspital Baselland/Bruderholz, Bruderholz, Switzerland</aff><aff id="I5"><label>5</label>B&#x000fc;rgerspital, Solothurn, Switzerland</aff><aff id="I6"><label>6</label>Inselspital, Bern University Hospital, Bern, Switzerland</aff><aff id="I7"><label>7</label>H&#x000f4;pital du Jura, Site de Del&#x000e9;mont, Del&#x000e9;mont, Switzerland</aff><aff id="I8"><label>8</label>Viollier SA, Basel, Switzerland</aff><pub-date pub-type="ppub"><year>2015</year></pub-date><pub-date pub-type="epub"><day>16</day><month>3</month><year>2015</year></pub-date><volume>19</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">35th International Symposium on Intensive Care and Emergency Medicine</named-content><named-content content-type="supplement-sponsor">Pubication charges for this supplement were funded by ISICEM.</named-content></supplement><fpage>P125</fpage><lpage>P125</lpage><permissions><copyright-statement>Copyright &#x000a9; 2015 Blum et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Blum et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://ccforum.com/content/19/S1/P125"/><conference><conf-date>17-20 March 2015</conf-date><conf-name>35th International Symposium on Intensive Care and Emergency Medicine</conf-name><conf-loc>Brussels, Belgium</conf-loc></conference></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Clinical trials yielded conflicting data about the benefit of adding systemic corticosteroids for community-acquired pneumonia (CAP). We evaluated whether short-term corticosteroid treatment reduces time to clinical stability in patients hospitalized for CAP.</p></sec><sec sec-type="methods"><title>Methods</title><p>This randomized, placebo-controlled multicenter trial compared prednisone 50 mg for 7 days with placebo in patients hospitalized with CAP. The primary endpoint was time to clinical stability.</p></sec><sec sec-type="results"><title>Results</title><p>Overall, 802 patients were randomized in seven Swiss hospitals from December 2009 to May 2014. Time to clinical stability was shorter in the prednisone group compared with placebo (3.0 vs. 4.4 days, HR = 1.33, 95% CI = 1.15 to 1.50, <italic>P </italic>&#x0003c; 0.001). The prednisone group as compared with the placebo group had a shorter time to hospital discharge (6 vs. 7 days (HR = 1.19, 1.04 to 1.38), <italic>P </italic>= 0.012) and a shorter duration of intravenous antibiotic treatment (4 vs. 5 days (difference, -0.89 days, -0.20 to -1.57 days), <italic>P </italic>= 0.011). All-cause mortality, ICU stay, recurrent pneumonia and rehospitalization rate were similar in both groups. Incidence of pneumonia-associated complications until day 30 tended to be lower in the prednisone group (2.8% vs. 5.6%, OR = 0.49, 0.23 to 1.02, <italic>P </italic>= 0.06). The prednisone group had a higher rate of in-hospital hyperglycemia needing insulin treatment (19.4% vs. 10.9%, OR = 1.96, 1.31 to 2.93, <italic>P </italic>= 0.001). Other adverse events compatible with corticosteroid use were rare and similar in both groups.</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>Prednisone treatment for 7 days in hospitalized patients with CAP shortens time to clinical stability, time to hospital discharge and duration of intravenous antibiotic treatment without an increase in complications.</p></sec></body></article>